Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
Trade XBI with:
  • Price/Earnings ttm 9.25
  • Annual Dividend & Yield 0.32
  • Most Recent Dividend 0.040
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 30.31%
  • Historical Volatility 44.38%
  • IV Percentile 5%
  • IV Rank 11.90%
  • IV High 51.08% on 04/21/20
  • IV Low 27.50% on 11/25/20
  • Put/Call Vol Ratio 1.05
  • Today's Volume 59,446
  • Volume Avg (30-Day) 38,490
  • Put/Call OI Ratio 1.70
  • Today's Open Interest 469,869
  • Open Int (30-Day) 313,348

Price Performance

See More
Period Period Low Period High Performance
1-Month
126.09 +2.24%
on 04/12/21
149.24 -13.62%
on 03/16/21
-17.60 (-12.01%)
since 03/12/21
3-Month
126.09 +2.24%
on 04/12/21
174.79 -26.25%
on 02/09/21
-19.66 (-13.23%)
since 01/13/21
52-Week
83.78 +53.87%
on 04/15/20
174.79 -26.25%
on 02/09/21
+45.61 (+54.75%)
since 04/13/20

Most Recent Stories

More News
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

AZN : 49.19 (-0.47%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
NVAX : 194.66 (+10.82%)
IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
FBT : 158.92 (+0.79%)
BTEC : 57.07 (+1.75%)
BNTX : 129.64 (+6.68%)
Will ETFs Gain on AstraZeneca's Latest Covid-19 Vaccine Update?

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence thanks to multiple mutants.

AZN : 49.19 (-0.47%)
MRNA : 149.71 (+7.40%)
NVAX : 194.66 (+10.82%)
IBB : 149.21 (+1.85%)
CNCR : 28.00 (+0.32%)
XBI : 128.91 (+1.46%)
PPH : 67.96 (-0.28%)
BBH : 178.70 (+1.85%)
Novavax ETFs to Shine Bright on Positive Vaccine Update

Investors are closely tracking the progress in coronavirus vaccine development and distribution amid the pandemic.

JNJ : 159.48 (-1.34%)
NVAX : 194.66 (+10.82%)
IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
GERM : 35.21 (+3.26%)
5 ETF Investing Areas for March to Boost Returns

Here we discuss a few ETFs that can enrich investors' portfolio in March amid a strong wave of optimism surrounding the coronavirus vaccine and introduction of another round of fiscal stimulus.

JNJ : 159.48 (-1.34%)
XLE : 47.86 (+0.10%)
IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
FMAT : 44.81 (-0.42%)
IBUY : 129.16 (+1.61%)
BOTZ : 34.75 (+0.87%)
SKYY : 102.40 (+1.58%)
CLIX : 86.37 (+1.84%)
ROBT : 53.99 (+0.95%)
CLOU : 27.44 (+1.93%)
Stocks Off to a Solid Start in March: 6 Bargain ETF Picks

Given the jump in investors' sentiment, ETFs that still trade at bargain price seem excellent pick.

JNJ : 159.48 (-1.34%)
SPY : 412.86 (+0.30%)
IEO : 47.07 (-0.04%)
XBI : 128.91 (+1.46%)
SDIV : 13.82 (+0.14%)
IAK : 76.33 (-0.14%)
FDM : 59.52 (-0.93%)
DEEP : 34.16 (-1.07%)
How Will Biotech ETFs React to These Q4 Earnings Releases?

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.

BIIB : 266.19 (+1.29%)
ALXN : 153.73 (-0.18%)
GILD : 64.89 (+0.36%)
AMGN : 249.95 (+0.41%)
IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
Novavax (NVAX) ETFs to Rise on Impressive Coronavirus Vaccine Update

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

MRNA : 149.71 (+7.40%)
NVAX : 194.66 (+10.82%)
IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
GERM : 35.21 (+3.26%)
Can Moderna ETFs Gain on COVID Vaccine Update Against Variants?

Positive coronavirus vaccine update from Moderna (MRNA) has hogged investors' attention.

MRNA : 149.71 (+7.40%)
IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
BTEC : 57.07 (+1.75%)
GERM : 35.21 (+3.26%)
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
LLY : 182.53 (+0.39%)
IBB : 149.21 (+1.85%)
CNCR : 28.00 (+0.32%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
FBT : 158.92 (+0.79%)
SBIO : 47.10 (+1.23%)
PBE : 73.63 (+1.78%)
BTEC : 57.07 (+1.75%)
ARKG : 89.32 (+3.12%)
BNTX : 129.64 (+6.68%)
ETF Areas Thriving During Coronavirus Pandemic

We highlight some ETF areas that held their ground and gained popularity among investors amid the coronavirus crisis.

HERO : 33.16 (+1.38%)
IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
IBUY : 129.16 (+1.61%)
SKYY : 102.40 (+1.58%)
CLIX : 86.37 (+1.84%)
ESGU : 94.86 (+0.40%)
ESPO : 71.60 (+1.52%)
CLOU : 27.44 (+1.93%)
USSG : 37.96 (+0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 132.84
2nd Resistance Point 130.93
1st Resistance Point 129.92
Last Price 128.91
1st Support Level 127.00
2nd Support Level 125.09
3rd Support Level 124.08

See More

52-Week High 174.79
Fibonacci 61.8% 140.02
Fibonacci 50% 129.29
Last Price 128.91
Fibonacci 38.2% 118.55
52-Week Low 83.78

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar